McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726

Article  CAS  PubMed  Google Scholar 

Butler J, Packer M, Filippatos G, Ferreira JP, Zeller C, Schnee J et al (2022) Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction. Eur Heart J 43(5):416–426

Article  CAS  PubMed  Google Scholar 

Jhund PS, Kondo T, Butt JH, Docherty KF, Claggett BL, Desai AS et al (2022) Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER. Nat Med 28(9):1956–1964

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cox ZL, Collins SP, Aaron M, Hernandez GA, Iii ATM, Davidson BT et al (2021) Efficacy and safety of dapagliflozin in acute heart failure: rationale and design of the DICTATE-AHF trial. Am Heart J 232:116–124

Article  CAS  PubMed  Google Scholar 

Biegus J, Voors AA, Collins SP, Kosiborod MN, Teerlink JR, Angermann CE et al (2023) Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial. Eur Heart J 44(1):41–50

Article  CAS  PubMed  Google Scholar 

Cox ZL, Collins SP, Hernandez GA, McRae AT 3rd, Davidson BT, Adams K et al (2024) Efficacy and safety of dapagliflozin in patients with acute heart failure. J Am Coll Cardiol 83(14):1295–1306

Article  CAS  PubMed  Google Scholar 

Iung B, Delgado V, Rosenhek R, Price S, Prendergast B, Wendler O et al (2019) Contemporary presentation and management of valvular heart disease: the EURObservational Research Programme Valvular Heart Disease II Survey. Circulation 140(14):1156–1169

Article  PubMed  Google Scholar 

Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J et al (2022) 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 43(7):561–632

Article  PubMed  Google Scholar 

Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F et al (2021) 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 77(4):450–500

Article  PubMed  Google Scholar 

Pascual-Figal DA, Zamorano JL, Domingo M, Morillas H, Nuñez J, Cobo Marcos M et al (2023) Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: the DAPA-MODA study. Eur J Heart Fail 25(8):1352–1360

Article  CAS  PubMed  Google Scholar 

Lee MMY, Brooksbank KJM, Wetherall K, Mangion K, Roditi G, Campbell RT et al (2021) Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF). Circulation 143(6):516–525

Article  CAS  PubMed  Google Scholar 

Santos-Gallego CG, Vargas-Delgado AP, Requena-Ibanez JA, Garcia-Ropero A, Mancini D, Pinney S et al (2021) Randomized trial of empagliflozin in nondiabetic patients with heart failure and reduced ejection fraction. J Am Coll Cardiol 77(3):243–255

Article  CAS  PubMed  Google Scholar 

Tanaka H, Soga F, Tatsumi K, Mochizuki Y, Sano H, Toki H et al (2020) Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure. Cardiovasc Diabetol 19(1):6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ajmone Marsan N, Delgado V, Shah DJ, Pellikka P, Bax JJ, Treibel T et al (2023) Valvular heart disease: shifting the focus to the myocardium. Eur Heart J 44(1):28–40

Article  PubMed  Google Scholar 

Asrial AA, Reviono R, Soetrisno S, Setianto BY, Widyaningsih V, Nurwati I et al (2023) Effect of dapagliflozin on patients with rheumatic heart disease mitral stenosis. J Clin Med 12(18):5898

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kang DH, Park SJ, Shin SH, Hwang IC, Yoon YE, Kim HK et al (2024) Ertugliflozin for functional mitral regurgitation associated with heart failure: EFFORT trial. Circulation 149(24):1865–1874

Article  CAS  PubMed  Google Scholar 

Dhingra N, Verma S, Butler J (2024) SGLT2 inhibition in subjects with valvular heart disease: a pooled analysis of the EMPEROR program. Am Assoc Thorac Surg